A Study of Gefapixant (AF-219/MK-7264) in Participants With Idiopathic Pulmonary Fibrosis (IPF) With Persistent Cough (MK-7264-016)
Clinical trial NCT02502097 · COMPLETED
Trial details
- NCT number
- NCT02502097
- Sponsor
- Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-26
- Primary completion
- 2016-07-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.